Plasma sRAGE is independently associated with urinary albumin excretion in type 2 diabetes

被引：38

作者：

Humpert, PM ^{[1
]}

Kopf, S ^{[1
]}

Djuric, Z ^{[1
]}

Wendt, T ^{[1
]}

Morcos, M ^{[1
]}

Nawroth, PP ^{[1
]}

Bierhaus, A ^{[1
]}

机构：

[1] Univ Klinikum Heidelberg, Med Klin 1, D-69120 Heidelberg, Germany

来源：

DIABETES CARE | 2006年 / 29卷 / 05期

关键词：

D O I：

10.2337/dc05-2478

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1111 / 1113

页数：3

共 17 条

[1]

ABEL M, 1995, NEPHROL DIAL TRANSPL, V10, P1662

[2] Understanding RAGE, the receptor for advanced glycation end products [J].

Bierhaus, A ;

Humpert, PM ;

Morcos, M ;

Wendt, T ;

Chavakis, T ;

Arnold, B ;

Stern, DM ;

Nawroth, PP .

JOURNAL OF MOLECULAR MEDICINE-JMM, 2005, 83 (11) :876-886

[3] Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily [J].

Bierhaus, A ;

Haslbeck, KM ;

Humpert, PM ;

Liliensiek, B ;

Dehmer, T ;

Morcos, M ;

Sayed, AAR ;

Andrassy, M ;

Schiekofer, S ;

Schneider, JG ;

Schulz, JB ;

Heuss, D ;

Neundörfer, B ;

Dierl, S ;

Huber, J ;

Tritschler, H ;

Schmidt, AM ;

Schwaninger, M ;

Haering, HU ;

Schleicher, E ;

Kasper, M ;

Stern, DM ;

Arnold, B ;

Nawroth, PP .

JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (12) :1741-1751

[4] RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice [J].

Bucciarelli, LG ;

Wendt, T ;

Qu, W ;

Lu, Y ;

Lalla, E ;

Rong, LL ;

Goova, MT ;

Moser, B ;

Kislinger, T ;

Lee, DC ;

Kashyap, Y ;

Stern, DM ;

Schmidt, AM .

CIRCULATION, 2002, 106 (22) :2827-2835

[5] Increased serum concentrations of soluble receptor for advanced glycation endproducts in patients with type 1 diabetes [J].

Challier, M ;

Jacqueminet, S ;

Benabdesselam, O ;

Grimaldi, A ;

Beaudeux, JL .

CLINICAL CHEMISTRY, 2005, 51 (09) :1749-1750

[6] Long-term renal effects of a neutralizing RAGE antibody in obese type 2 diabetic mice [J].

Flyvbjerg, A ;

Denner, L ;

Schrijvers, BF ;

Tilton, RG ;

Mogensen, TH ;

Paludan, SR ;

Rasch, R .

DIABETES, 2004, 53 (01) :166-172

[7] Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy [J].

Forbes, JM ;

Thorpe, SR ;

Thallas-Bonke, V ;

Pete, J ;

Thomas, MC ;

Deemer, ER ;

Bassal, S ;

El-Osta, A ;

Long, DM ;

Panagiotopoulos, S ;

Jerums, G ;

Osicka, TM ;

Cooper, ME .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (08) :2363-2372

[8] Decreased endogenous secretory advanced glycation end product receptor in type 1 diabetic patients - Its possible association with diabetic vascular complications [J].

Katakami, N ;

Matsuhisa, M ;

Kaneto, H ;

Matsuoka, TA ;

Sakamoto, K ;

Nakatani, Y ;

Ohtoshi, K ;

Hayaishi-Okano, R ;

Kosugi, K ;

Hori, M ;

Yamasaki, Y .

DIABETES CARE, 2005, 28 (11) :2716-2721

[9] Nε-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression [J].

Kislinger, T ;

Fu, CF ;

Huber, B ;

Qu, W ;

Taguchi, A ;

Yan, SD ;

Hofmann, M ;

Yan, SF ;

Pischetsrieder, M ;

Stern, D ;

Schmidt, AM .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (44) :31740-31749

[10] Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis [J].

Koyama, H ;

Shoji, T ;

Yokoyama, H ;

Motoyama, K ;

Mori, K ;

Fukumoto, S ;

Emoto, M ;

Shoji, T ;

Tamei, H ;

Matsuki, H ;

Sakurai, S ;

Yamamoto, Y ;

Yonekura, H ;

Watanabe, T ;

Yamamoto, H ;

Nishizawa, Y .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (12) :2587-2593

← 1 2 →